Yıl: 2023 Cilt: 3 Sayı: 1 Sayfa Aralığı: 26 - 31 Metin Dili: İngilizce DOI: 10.14744/eer.2022.02996 İndeks Tarihi: 01-06-2023

Orbital rhabdomyosarcoma: Review

Öz:
Orbital rhabdomyosarcoma is the most common malignant orbital tumor of child-hood originating from mesenchymal cells. The presenting symptom is usually acute onset unilateral proptosis. The rapidly progressive course of the findings may resemble infectious and inflammatory orbital diseases. Radiological imaging and histopathological examinations are crucial for differential diagnosis. The main goal of treatment with a multidisciplinary approach is to control both local and distant spread of the tumor and to prevent further damage. With the introduction of chemotherapy and radiotherapy in the treatment, the overall survival rate has in-creased. Thus, aggressive surgical approach for complete removal of the tumor has been abandoned.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Derleme Erişim Türü: Erişime Açık
  • 1. Darsaut TE, Lanzino G, Lopes MB, Newman S. An introductory overview of orbital tumors. Neurosurg Focus 2001;10:E1.
  • 2. Topilow NJ, Tran AQ, Koo EB, Alabiad CR. Etiologies of propto- sis: A review. Intern Med Rev (Wash DC) 2020;6:852
  • 3. Pontes FS, de Oliveira JI, de Souza LL, de Almeida OP, Fregnani ER, Vilela RS, et al. Clinicopathological analysis of head and neck rhabdomyosarcoma: A series of 10 cases and literature review. Med Oral Patol Oral Cir Bucal 2018;23:e188–97.
  • 4. Parham DM, Alaggio R, Coffin CM. Myogenic tumors in chil- dren and adolescents. Pediatr Dev Pathol 2012;15:211–38.
  • 5. Cortes Barrantes P, Jakobiec FA, Dryja TP. A review of the role of cytogenetics in the diagnosis of orbital rhabdomyosarco- ma. Semin Ophthalmol 2019;34:243–51.
  • 6. Medel R, Balaguer Ó. Approach to diagnosis of orbital tu- mours. In: ESASO Course Series. Vol. 5. Basel, Switzerland: Karger Publishers; 2014. p. 46–72.
  • 7. Kaliaperumal S, Tiroumal S, Rao VA. Orbital rhabdomyosarco- ma: A case series. Indian J Cancer 2007;44:104.
  • 8. Yazıcı B, Sabur H, Yazıcı Z. Orbital cavitary rhabdomyosarco- ma: Case report and literature review. Ophthal Plast Reconstr Surg 2014;30:e20–2.
  • 9. Shields CL, Shields JA, Honavar SG, Demirci H. Clinical spec- trum of primary ophthalmic rhabdomyosarcoma. Ophthal- mology 2001;108:2284–92.
  • 10. Lee RJ, Lee KK, Lin T, Arshi A, Lee SA, Christensen RE. Rhabdo- myosarcoma of the head and neck: İmpact of demographic and clinicopathologic factors on survival. Oral Surg Oral Med Oral Pathol Oral Radiol 2017;124:271–9.
  • 11. Kim J, Ussher JG. Orbital rhabdomyosarcoma: A rare ophthal- mic condition. Med J Aust 2019;211:398–9.e1.
  • 12. Chaugule SS, Honavar SG, Finger PT. Surgical Ophthalmic Oncology: A Collaborative Open Access Reference. Germany: Springer Nature; 2019.
  • 13. Oraegbunam NH, Ezeh EI, Etiowo N, Ezeh RN. Atypical presentations of orbital cellulitis in an 11-year-old boy. Calabar J Health Sci 2020;4:40–3.
  • 14. Cota N, Chandna A, Abernethy LJ. Orbital abscess masquerad- ing as a rhabdomyosarcoma. J AAPOS 2000;4:318–20.
  • 15. Amir SP, Kamaruddin MI, Akib MN, Sirajuddin J. Orbital celluli- tis clinically mimicking rhabdomyosarcoma. Int Med Case Rep J 2019;12:285–9.
  • 16. Nayak BK, Desai S, Maheshwari S. Interpretation of magnetic resonance imaging of orbit: Simplified for ophthalmologists (Part I). J Clin Ophthalmol Res 2013;1:29–35.
  • 17. Debnam JM, Mayer RR, Esmaeli B, Weinberg JS, Demon- te F, Guha-Thakurta N. Three-dimensional multidetector CT for anatomic evaluation of orbital tumors. J Ophthalmol 2013;2013:674230.
  • 18. Gokharman D, Aydin S. Magnetic resonance ımaging in or - bital pathologies: A pictorial review. J Belgian Soc Radiol 2018;101:5.
  • 19. Héran F, Bergès O, Blustajn J, Boucenna M, Charbonneau F, Koskas P, et al. Tumor pathology of the orbit. Diagn Interv Im- aging 2014;95:933–44.
  • 20. Shields JA, Shields CL. Rhabdomyosarcoma: Review for the ophthalmologist. Surv Ophthalmol 2003;48:39–57.
  • 21. Kralik S, Haider K, Lobo R, Supakul N, Calloni S, Soares B. Orbit- al infantile hemangioma and rhabdomyosarcoma in children: Differentiation using diffusion-weighted magnetic resonance imaging. JAAPOS 2017;22:27–31.
  • 22. Jurdy L, Merks JH, Pieters BR, Mourits MP, Kloos RJ, Strackee SD, et al. Orbital rhabdomyosarcomas: A review. Saudi J Oph- thalmol 2013;27:167–75.
  • 23. Ting DS, Perez-Lopez M, Chew NJ, Clarke L, Dickinson AJ, Neoh C. A 10-year review of orbital biopsy: The newcastle eye centre study. Eye (Lond) 2015;29:1162–6.
  • 24. Yanoff M, Duker JS. Ophthalmology. Netherlands: Elsevier Health Sciences; 2018.
  • 25. Grossniklaus HE, Eberhart CG, Kivelä TT. WHO Classification of Tumours of the Eye. Lyon, France: IARC; 2018.
  • 26. Oberlin O, Rey A, Anderson J, Carli M, Raney RB, Treuner J, et al. Treatment of orbital rhabdomyosarcoma: Survival and late effects of treatment--results of an international workshop. J Clin Oncol 2001;19:197–204.
  • 27. Boutroux H, Levy C, Mosseri V, Desjardins L, Plancher C, Helfre S, et al. Long-term evaluation of orbital rhabdomyosarcoma in children. Clin Exp Ophthalmol 2015;43:12–9.
  • 28. Frayer WC, Enterlıne HT. Embryonal rhabdomyosarcoma of the orbit in children and young adults. AMA Arch Ophthalmol 1959;62:203–10.
  • 29. Karcioglu ZA, Hadjistilianou D, Rozans M, DeFrancesco S. Or - bital rhabdomyosarcoma. Cancer Control 2004;11:328–33.
  • 30. Zhang Y, He C, Lian Y, Xiao H. Score for the survival prob- ability of patients with orbital rhabdomyosarcoma after surgery: A long-term and large cohort study. Front Oncol 2020;10:1590.
  • 31. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruy- mann FB, et al. Intergroup rhabdomyosarcoma study-IV: Re- sults for patients with nonmetastatic disease. J Clin Oncol 2001;19:3091–102.
  • 32. Arndt CA, Stoner JA, Hawkins DS, Rodeberg DA, Hayes-Jor- dan AA, Paidas CN, et al. Vincristine, actinomycin, and cyclo- phosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosar- coma: Children’s oncology group study D9803. J Clin Oncol 2009;27:5182–8.
  • 33. Fiorillo A, Migliorati R, Vassallo P, Canale G, Tranfa F, Fariello I, et al. Radiation late effects in children treated for orbital rhab- domyosarcoma. Radiother Oncol 1999;53:143–8.
  • 34. Goldberg SH, Cantore WA. Tumors of the orbit. Curr Opin Oph- thalmol 1997;8:51–6.
  • 35. Tang LY, Zhang MX, Lu DH, Chen YX, Liu ZG, Wu SG. The prog- nosis and effects of local treatment strategies for orbital em- bryonal rhabdomyosarcoma: A population-based study. Can- cer Manag Res 2018;10:1727–34.
APA korkmaz i, Yaman B, Ceylan N, Kantar M, Kamer S, Palamar M (2023). Orbital rhabdomyosarcoma: Review. , 26 - 31. 10.14744/eer.2022.02996
Chicago korkmaz ilayda,Yaman Banu,Ceylan Naim,Kantar Mehmet,Kamer Serra,Palamar Melis Orbital rhabdomyosarcoma: Review. (2023): 26 - 31. 10.14744/eer.2022.02996
MLA korkmaz ilayda,Yaman Banu,Ceylan Naim,Kantar Mehmet,Kamer Serra,Palamar Melis Orbital rhabdomyosarcoma: Review. , 2023, ss.26 - 31. 10.14744/eer.2022.02996
AMA korkmaz i,Yaman B,Ceylan N,Kantar M,Kamer S,Palamar M Orbital rhabdomyosarcoma: Review. . 2023; 26 - 31. 10.14744/eer.2022.02996
Vancouver korkmaz i,Yaman B,Ceylan N,Kantar M,Kamer S,Palamar M Orbital rhabdomyosarcoma: Review. . 2023; 26 - 31. 10.14744/eer.2022.02996
IEEE korkmaz i,Yaman B,Ceylan N,Kantar M,Kamer S,Palamar M "Orbital rhabdomyosarcoma: Review." , ss.26 - 31, 2023. 10.14744/eer.2022.02996
ISNAD korkmaz, ilayda vd. "Orbital rhabdomyosarcoma: Review". (2023), 26-31. https://doi.org/10.14744/eer.2022.02996
APA korkmaz i, Yaman B, Ceylan N, Kantar M, Kamer S, Palamar M (2023). Orbital rhabdomyosarcoma: Review. European eye research, 3(1), 26 - 31. 10.14744/eer.2022.02996
Chicago korkmaz ilayda,Yaman Banu,Ceylan Naim,Kantar Mehmet,Kamer Serra,Palamar Melis Orbital rhabdomyosarcoma: Review. European eye research 3, no.1 (2023): 26 - 31. 10.14744/eer.2022.02996
MLA korkmaz ilayda,Yaman Banu,Ceylan Naim,Kantar Mehmet,Kamer Serra,Palamar Melis Orbital rhabdomyosarcoma: Review. European eye research, vol.3, no.1, 2023, ss.26 - 31. 10.14744/eer.2022.02996
AMA korkmaz i,Yaman B,Ceylan N,Kantar M,Kamer S,Palamar M Orbital rhabdomyosarcoma: Review. European eye research. 2023; 3(1): 26 - 31. 10.14744/eer.2022.02996
Vancouver korkmaz i,Yaman B,Ceylan N,Kantar M,Kamer S,Palamar M Orbital rhabdomyosarcoma: Review. European eye research. 2023; 3(1): 26 - 31. 10.14744/eer.2022.02996
IEEE korkmaz i,Yaman B,Ceylan N,Kantar M,Kamer S,Palamar M "Orbital rhabdomyosarcoma: Review." European eye research, 3, ss.26 - 31, 2023. 10.14744/eer.2022.02996
ISNAD korkmaz, ilayda vd. "Orbital rhabdomyosarcoma: Review". European eye research 3/1 (2023), 26-31. https://doi.org/10.14744/eer.2022.02996